| |
아미노산 배열 |
Catalog # |
제품명 |
포장단위 |
| | (Asp)2-R110 | 81-6-26A | Rhodamine 110, bis-(L-aspartic acid amide), trifluoroacetic acid salt | 0.5?mg |
| | (Asp)2-R110 | 81-6-26B | Rhodamine 110, bis-(L-aspartic acid amide), trifluoroacetic acid salt | 1.0?mg |
| | (Hexahydro-1H-azepinyl)carbonyl-Leu-(1-Me)-DTrp-DTyr | 88-2-47A | PD-151242 | 0.5?mg |
| | (Hexahydro-1H-azepinyl)carbonyl-Leu-(1-Me)-DTrp-DTyr | 88-2-47B | PD-151242 | 1.0?mg |
| | (Hexahydro-1H-azepinyl)carbonyl-Leu-D-(1-Me)-Trp-DPal | 88-2-46A | FR139317 | 0.5?mg |
| | (Hexahydro-1H-azepinyl)carbonyl-Leu-D-(1-Me)-Trp-DPal | 88-2-46B | FR139317 | 1.0?mg |
| | (NMe)Tyr-Gly-Gly-Phe-Leu-Arg-(NMe)Arg-DLeu-NHEt | 26-4-49A | E-2078 | 0.5?mg |
| | (NMe)Tyr-Gly-Gly-Phe-Leu-Arg-(NMe)Arg-DLeu-NHEt | 26-4-49B | E-2078 | 1.0?mg |
| | (NMe)Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-NH2 | 26-4-54 | [(NMe)Tyr1] Dynorphin A (1-13), amide, porcine | 1.0?mg |
| | (R)-N2-(diphenylacetyl)-N-[(n-hydroxyphenyl)methy1]-Arg-NH2 | 60-1-22A | BIBP 3226 | 0.5?mg |
| | (R)-N2-(diphenylacetyl)-N-[(n-hydroxyphenyl)methy1]-Arg-NH2 | 60-1-22B | BIBP 3226 | 1.0?mg |
| | (Suc-Ala-Ala-Pro-Phe)2-R110 | 82-0-07A | Rhodamine 110, bis-(succinoyl-L-alanyl-L-alanyl-L- prolyl-L-phenylalanyl amide) | 0.5?mg |
| | (Suc-Ala-Ala-Pro-Phe)2-R110 | 82-0-07B | Rhodamine 110, bis-(succinoyl-L-alanyl-L-alanyl-L- prolyl-L-phenylalanyl amide) | 1.0?mg |
| | (Tos-Gly-Pro-Arg)2-R110 | 82-0-06A | Rhodamine 110, bis-(p-tosyl-L-glycyl-L-prolyl-L- arginine amide) | 0.5?mg |
| | (Tos-Gly-Pro-Arg)2-R110 | 82-0-06B | Rhodamine 110, bis-(p-tosyl-L-glycyl-L-prolyl-L- arginine amide) | 1.0?mg |
| | (Z-Ala-Ala)2-R110 | 82-0-00A | Rhodamine 110, bis-(CBZ-L-alanyl-L-alanine amide) | 0.5?mg |
| | (Z-Ala-Ala)2-R110 | 82-0-00B | Rhodamine 110, bis-(CBZ-L-alanyl-L-alanine amide) | 1.0?mg |
| | (Z-Ala-Ala-Ala-Ala-)2-R110 | 82-0-01A | Rhodamine 110, bis-(CBZ-L-alanyl-L-alanyl-L-alanyl-L- alanine amide) | 0.5?mg |
| | (Z-Ala-Ala-Ala-Ala-)2-R110 | 82-0-01B | Rhodamine 110, bis-(CBZ-L-alanyl-L-alanyl-L-alanyl-L- alanine amide) | 1.0?mg |
| | (Z-Ala-Arg)2-R110 | 82-0-02A | Rhodamine 110, bis-(CBZ-L-alanyl-L-arginine amide), dihydrochloride | 0.5?mg |
| | (Z-Ala-Arg)2-R110 | 82-0-02B | Rhodamine 110, bis-(CBZ-L-alanyl-L-arginine amide), dihydrochloride | 1.0?mg |
| | (Z-Arg)2-R110 | 82-0-03A | Rhodamine 110, bis-(CBZ-L-arginine amide), dihydrochloride (BZAR) | 0.5?mg |
| | (Z-Arg)2-R110 | 82-0-03B | Rhodamine 110, bis-(CBZ-L-arginine amide), dihydrochloride (BZAR) | 1.0?mg |
| | (Z-Asp-Glu-Val-Asp)2-R110 | 81-6-25A | Z-DEVD-R110 | 0.5?mg |
| | (Z-Asp-Glu-Val-Asp)2-R110 | 81-6-25B | Z-DEVD-R110 | 1.0?mg |
| | (Z-Ile-Glu-Thr-Asp)-R110 | 81-8-01A | Z-IETD-R110 | 0.5?mg |
| | (Z-Ile-Glu-Thr-Asp)-R110 | 81-8-01B | Z-IETD-R110 | 1.0?mg |
| | (Z-Ile-Pro-Arg)2-R110 | 82-0-04A | Rhodamine 110, bis-(CBZ-L-isoleucyl-L-prolyl-L- arginine amide), dihydrochloride (BZiPAR) | 0.5?mg |
| | (Z-Ile-Pro-Arg)2-R110 | 82-0-04B | Rhodamine 110, bis-(CBZ-L-isoleucyl-L-prolyl-L- arginine amide), dihydrochloride (BZiPAR) | 1.0?mg |
| | (Z-Phe-Arg)2-R110 | 82-0-05A | Rhodamine 110, bis-(CBZ-L-phenylalanyl-L-arginine amide), dihydrochloride | 0.5?mg |
| | (Z-Phe-Arg)2-R110 | 82-0-05B | Rhodamine 110, bis-(CBZ-L-phenylalanyl-L-arginine amide), dihydrochloride | 1.0?mg |
| | 4-(4-Dimethylaminophenylazo)benzoyl-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-5-[(2-aminoethyl)amino]-naphthalene-1-sulfonic acid | 72-3-30A | DABCYL-y-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | 0.5?mg |
| | 4-(4-Dimethylaminophenylazo)benzoyl-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-5-[(2-aminoethyl)amino]-naphthalene-1-sulfonic acid | 72-3-30B | DABCYL-y-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | 1.0?mg |
| | 4-(4-Dimethylaminophenylazo)benzoyl-Tyr-Val-Ala-Asp-Ala-Pro-Val-5-[(2-aminoethyl)amino]-naphthalene-1-sulfonic acid | 81-0-15A | IL-1 b Converting Enzyme (ICE) Substrate II | 0.5?mg |
| | 4-(4-Dimethylaminophenylazo)benzoyl-Tyr-Val-Ala-Asp-Ala-Pro-Val-5-[(2-aminoethyl)amino]-naphthalene-1-sulfonic acid | 81-0-15B | IL-1 b Converting Enzyme (ICE) Substrate II | 1.0?mg |
| | 4-Abz-Gly-Pro-DLeu-DAla-NH-OH | 76-4-75A | MMP Inhibitor 1 | 0.5?mg |
| | 4-Abz-Gly-Pro-DLeu-DAla-NH-OH | 76-4-75B | MMP Inhibitor 1 | 1.0?mg |
| | Abz-Ala-Arg-Val-Nle-Tyr(NO2)-Glu-Ala-Nle-NH2 | 81-0-45A | Fluorescent HIV Substrate | 0.5?mg |
| | Abz-Ala-Arg-Val-Nle-Tyr(NO2)-Glu-Ala-Nle-NH2 | 81-0-45B | Fluorescent HIV Substrate | 1.0?mg |
| | Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide | 81-0-31A | Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide | 0.5?mg |
| | Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide | 81-0-31B | Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide | 1.0?mg |
| | Abz-Ala-Phe-Ala-Phe-Asp-Val-Phe-Tyr(NO2)-Asp | 81-0-50A | Fluorescent Substrate for Asp-Specific Proteases | 0.5?mg |
| | Abz-Ala-Phe-Ala-Phe-Asp-Val-Phe-Tyr(NO2)-Asp | 81-0-50B | Fluorescent Substrate for Asp-Specific Proteases | 1.0?mg |
| | Abz-Ala-Phe-Ala-Phe-Glu-Val-Phe-Tyr(NO2)-Asp | 81-0-30A | Fluorescent Substrate for Glu-Specific Proteases | 0.5?mg |
| | Abz-Ala-Phe-Ala-Phe-Glu-Val-Phe-Tyr(NO2)-Asp | 81-0-30B | Fluorescent Substrate for Glu-Specific Proteases | 1.0?mg |
| | Abz-Arg-Val-Lys-Arg-Gly-Leu-Ala-Tyr(NO2)-Asp | 81-6-20A | Furin Substrate | 0.5?mg |
| | Abz-Arg-Val-Lys-Arg-Gly-Leu-Ala-Tyr(NO2)-Asp | 81-6-20B | Furin Substrate | 1.0?mg |
| | Abz-Asp-Phe-Arg-Leu-Phe-Ala-Phe-Tyr-(NO2)-Asp | 81-0-10A | Fluorescent Substrate for Subtillsin | 0.5?mg |
| | Abz-Asp-Phe-Arg-Leu-Phe-Ala-Phe-Tyr-(NO2)-Asp | 81-0-10B | Fluorescent Substrate for Subtillsin | 1.0?mg |
| | Abz-Gly-Ala-Ala-Pro-Phe-Tyr(NO2)-Asp | 81-0-20A | Fluorescent Substrate for Pro-Specific Proteases | 0.5?mg |
| | Abz-Gly-Ala-Ala-Pro-Phe-Tyr(NO2)-Asp | 81-0-20B | Fluorescent Substrate for Pro-Specific Proteases | 1.0?mg |
| | Abz-His-Lys-Ala-Arg-Val-Leu-Tyr(NO2)-Glu-Ala-Nle-Ser-NH2 | 81-0-40A | Fluorescent HIV Substrate | 0.5?mg |
| | Abz-His-Lys-Ala-Arg-Val-Leu-Tyr(NO2)-Glu-Ala-Nle-Ser-NH2 | 81-0-40B | Fluorescent HIV Substrate | 1.0?mg |
| | Abz-Leu-Ala-Gln-Ala-Val-Arg-Ser-ser-Ser-Arg-Dap(Dnp)-NH2 | 81-0-32A | Abz-Leu-Ala-Gln-Ala-Val-Arg-Ser-ser-Ser-Arg-Dap(Dnp)-NH2 | 0.5?mg |
| | Abz-Leu-Ala-Gln-Ala-Val-Arg-Ser-ser-Ser-Arg-Dap(Dnp)-NH2 | 81-0-32B | Abz-Leu-Ala-Gln-Ala-Val-Arg-Ser-ser-Ser-Arg-Dap(Dnp)-NH2 | 1.0?mg |
| | Ac-(NMe)Tyr-Val-Ala-Asp-CHO | 81-7-24A | Ac-N-Me-Tyr-Val-Ala-Asp-CHO | 0.5?mg |
| | Ac-(NMe)Tyr-Val-Ala-Asp-CHO | 81-7-24B | Ac-N-Me-Tyr-Val-Ala-Asp-CHO | 1.0?mg |
| | Ac-(pCl)DPhe-(pCl)DPhe-DTrp-Ser-Tyr-DArg-Leu-Arg-Pro-DAla-NH2 | 54-0-38A | N-Acetyl [(pCl)DPhe1,2,DTrp3,DArg6,DAla10]-LH-RH | 0.5?mg |
| | Ac-(pCl)DPhe-(pCl)DPhe-DTrp-Ser-Tyr-DArg-Leu-Arg-Pro-DAla-NH2 | 54-0-38B | N-Acetyl [(pCl)DPhe1,2,DTrp3,DArg6,DAla10]-LH-RH | 1.0?mg |
| | Ac2-Lys-DAla-DAla | 80-0-13A | N,N,Diacetyl-Lys-DAla-DAla | 5.0?mg |
| | Ac2-Lys-DAla-DAla | 80-0-13B | N,N,Diacetyl-Lys-DAla-DAla | 25.0?mg |
| | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Glu-Val-Asp-CHO | 81-6-35A | Caspase-3 Inhibitor I, Cell-Permeable | 0.5?mg |
| | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Glu-Val-Asp-CHO | 81-6-35B | Caspase-3 Inhibitor I, Cell-Permeable | 1.0?mg |
| | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-CHO | 81-8-00A | Caspase-8 Inhibitor I, Cell Permeable | 0.5?mg |
| | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-CHO | 81-8-00B | Caspase-8 Inhibitor I, Cell Permeable | 1.0?mg |
| | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Tyr-Val-Ala-Asp-CHO | 81-6-36A | Caspase-1 Inhibitor I, Cell-Permeable | 0.5?mg |
| | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Tyr-Val-Ala-Asp-CHO | 81-6-36B | Caspase-1 Inhibitor I, Cell-Permeable | 1.0?mg |
| | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Ala-Asp-CHO | 81-6-34A | Caspase Inhibitor II, Cell-Permeable | 0.5?mg |
| | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Ala-Asp-CHO | 81-6-34B | Caspase Inhibitor II, Cell-Permeable | 1.0?mg |
| | Ac-Ala-Asp-Lys-Pro-Asp-Met-Gly-Glu-Ile-Ala-Ser-Phe-Asp-Lys-Ala-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Thr-Leu-Pro-Thr-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Arg-Ser-Glu-Ile-Ser | 74-1-15A | Thymosin b10 human, rat | 0.5?mg |
| | Ac-Ala-Asp-Lys-Pro-Asp-Met-Gly-Glu-Ile-Ala-Ser-Phe-Asp-Lys-Ala-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Thr-Leu-Pro-Thr-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Arg-Ser-Glu-Ile-Ser | 74-1-15B | Thymosin b10 human, rat | 1.0?mg |
| | Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His-Gly | 91-0-51A | Acetyl-Myelin Basic Protein (Human, Rat, 1-11) | 1.0?mg |
| | Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His-Gly | 91-0-51B | Acetyl-Myelin Basic Protein (Human, Rat, 1-11) | 5.0?mg |
| | Ac-Arg-Arg-Pro-Tyr-Ile-Leu | 62-1-26 | Neurotensin (8-13), N-Acetyl | 1.0?mg |
| | Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 | 32-0-54 | Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 | 1.0?mg |
| | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser | 12-4-10A | Acetyl Angiotensinogen (1-14), porcine | 1.0?mg |
| | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser | 12-4-10B | Acetyl Angiotensinogen (1-14), porcine | 5.0?mg |
| | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn | 12-1-79A | Acetyl, Angiotensinogen (1-14), human | 1.0?mg |
| | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn | 12-1-79B | Acetyl, Angiotensinogen (1-14), human | 5.0?mg |
| | Ac-Asp-DGla-Leu-Ile-Cha-Cys | 72-3-50A | Ac-Asp-DGla-Leu-Ile-b-cyclohexyl-Ala-Cys | 0.5?mg |
| | Ac-Asp-DGla-Leu-Ile-Cha-Cys | 72-3-50B | Ac-Asp-DGla-Leu-Ile-b-cyclohexyl-Ala-Cys | 1.0?mg |
| | Ac-Asp-Glu | 60-0-55 | Ac-Asp-Glu | 5.0?mg |
| | Ac-Asp-Glu-Val-Asp-AFC | 81-7-79 | Ac-Asp-Glu-Val-Asp-AFC | 1.0?mg |
| | Ac-Asp-Glu-Val-Asp-AMC | 81-6-30A | Apopain Substrate | 1.0?mg |
| | Ac-Asp-Glu-Val-Asp-AMC | 81-6-30B | Apopain Substrate | 5.0?mg |
| | Ac-Asp-Glu-Val-Asp-CHO | 81-6-31A | Rhodamine 110, bis-(L-aspartic acid amide), trifluoroacetic acid salt | 1.0?mg |
| | Ac-Asp-Glu-Val-Asp-CHO | 81-6-31B | Rhodamine 110, bis-(L-aspartic acid amide), trifluoroacetic acid salt | 5.0?mg |
| | Ac-Asp-Glu-Val-Asp-CMK | 81-6-32A | Rhodamine 110, bis-(L-aspartic acid amide), trifluoroacetic acid salt | 1.0?mg |
| | Ac-Asp-Glu-Val-Asp-CMK | 81-6-32B | Ac-DEVD-CMK | 5.0?mg |
| | Ac-Asp-Glu-Val-Asp-pNA | 81-6-40B | Ac-DEVD-pNA | 5.0?mg |
| | Ac-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | 88-2-53A | IRL-1720 | 0.5?mg |
| | Ac-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | 88-2-53B | IRL-1720 | 1.0?mg |
| | Ac-Asp-Met-Gln-Asp-AMC | 81-7-80 | Ac-Asp-Met-Gln-Asp-AMC | 1.0?mg |
| | Ac-Asp-Met-Gln-Asp-CHO | 81-7-12 | Ac-DMQD-CHO | 1.0?mg |
| | Ac-Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala-NH2 | 81-5-18A | Acetyl-Calpastatin (184-210), human | 0.5?mg |
| | Ac-Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala-NH2 | 81-5-18B | Acetyl-Calpastatin (184-210), human | 1.0?mg |
| | Ac-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 | 86-2-31A | Ac-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 | 0.5?mg |
| | Ac-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 | 86-2-31B | Ac-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 | 1.0?mg |
| | Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | 86-2-32A | Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | 0.5?mg |
| | Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | 86-2-32B | Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | 1.0?mg |
| | Ac-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-NH2 | 46-1-38A | N-Acetyl Cholecystokinin, CCK (26-31), Sulfated | 0.5?mg |
| | Ac-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-NH2 | 46-1-38B | N-Acetyl Cholecystokinin, CCK (26-31), Sulfated | 1.0?mg |
| | Ac-Asp-Tyr(SO3H)-Met-Gly-Trp-NH2 | 46-1-41A | N-Acetyl Cholecystokinin, CCK (26-30), Sulfated | 0.5?mg |
| | Ac-Asp-Tyr(SO3H)-Met-Gly-Trp-NH2 | 46-1-41B | N-Acetyl Cholecystokinin, CCK (26-30), Sulfated | 1.0?mg |
| | Ac-Asp-Tyr-Met-Gly-Trp-Met-NH2 | 46-1-39A | N-Acetyl Cholecystokinin, CCK (26-31), Non-Sulfated | 0.5?mg |
| | Ac-Asp-Tyr-Met-Gly-Trp-Met-NH2 | 46-1-39B | N-Acetyl Cholecystokinin, CCK (26-31), Non-Sulfated | 1.0?mg |
| | Ac-Cys-Glu-His-DPhe-Arg-Trp-Cys-Lys-Pro-Val-NH2 | 56-0-12 | [Ac-Cys4,DPhe7,Cys10] a-MSH (4-13), amide | 1.0?mg |
| | Ac-Cys-His-Ser-Gly-Tyr-Val-Gly-Val-Arg-Cys-OMe | 50-5-25 | N-Acetyl, a-TGF (34-43), Methyl Ester, rat | 1.0?mg |
| | Ac-DBhg-Leu-Asp-Ile-Ile-Trp | 88-2-33A | PD-145065 | 0.5?mg |
| | Ac-DBhg-Leu-Asp-Ile-Ile-Trp | 88-2-33B | PD-145065 | 1.0?mg |
| | Ac-DDip-Leu-Asp-Ile-Ile-Trp | 88-2-43A | PD 142893 | 0.5?mg |
| | Ac-DDip-Leu-Asp-Ile-Ile-Trp | 88-2-43B | PD 142893 | 1.0?mg |
| | Ac-DNal-D-(p-Cl)Phe-DPal-Ser-Lys(nicotinoyl)-DLys(nicotinoyl)-Leu-Lys(isopropyl)-Pro-DAla-NH2 | 54-1-24A | Antide | 1.0?mg |
| | Ac-DNal-D-(p-Cl)Phe-DPal-Ser-Lys(nicotinoyl)-DLys(nicotinoyl)-Leu-Lys(isopropyl)-Pro-DAla-NH2 | 54-1-24B | Antide | 5.0?mg |
| | Ac-DTrp-Leu-Asp-lle-lle-Trp | 88-2-44A | Ac-[DTrp16] Endothelin-1 (16-21), human | 0.5?mg |
| | Ac-DTrp-Leu-Asp-lle-lle-Trp | 88-2-44B | Ac-[DTrp16] Endothelin-1 (16-21), human | 1.0?mg |
| | Ac-Gln-Leu-Lys-Thr-Ala-Asp-Leu-Pro-Ala-Gly-Arg-Asp-Glu-Thr-Thr-Ser-Phe-Val-Leu-Val-NH2 | 72-2-29A | Acetyl-Adhesin (1025-1044) amide | 0.5?mg |
| | Ac-Gln-Leu-Lys-Thr-Ala-Asp-Leu-Pro-Ala-Gly-Arg-Asp-Glu-Thr-Thr-Ser-Phe-Val-Leu-Val-NH2 | 72-2-29B | Acetyl-Adhesin (1025-1044) amide | 1.0?mg |
| | Ac-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | 86-2-45A | Ac-MBP (4-14) Peptide | 0.5?mg |
| | Ac-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | 86-2-45B | Ac-MBP (4-14) Peptide | 1.0?mg |
| | Ac-Glu-Glu-Val-Val-Ala-Cys-AMC | 72-3-20A | Ac-Glu-Glu-Val-Val-Ala-Cys-AMC | 0.5?mg |
| | Ac-Glu-Glu-Val-Val-Ala-Cys-AMC | 72-3-20B | Ac-Glu-Glu-Val-Val-Ala-Cys-AMC | 1.0?mg |
| | Ac-Glu-Glu-Val-Val-Ala-Cys-pNA | 72-3-21A | Ac-Glu-Glu-Val-Val-Ala-Cys-pNA | 0.5?mg |
| | Ac-Glu-Glu-Val-Val-Ala-Cys-pNA | 72-3-21B | Ac-Glu-Glu-Val-Val-Ala-Cys-pNA | 1.0?mg |
| | Ac-Glu-Ser-Met-Asp-CHO | 81-7-82 | Ac-Glu-Ser-Met-Asp-CHO | 1.0?mg |
| | Ac-His-Leu-Asp-Ile-Ile-Trp | 88-2-34A | Ac-Endothelin-1 (16-21), human | 0.5?mg |
| | Ac-His-Leu-Asp-Ile-Ile-Trp | 88-2-34B | Ac-Endothelin-1 (16-21), human | 1.0?mg |
| | Ac-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | 46-4-37 | Acetyl, Gastrin Releasing Peptide (20-27), porcine | 1.0?mg |
| | Ac-Ile-Glu-Pro-Asp-AMC | 81-8-02 | Ac-Ile-Glu-Pro-Asp-AMC | 1.0?mg |
| | Ac-Ile-Glu-Pro-Asp-CHO | 81-8-05A | Caspase-8 Inhibitor | 1.0?mg |
| | Ac-Ile-Glu-Pro-Asp-CHO | 81-8-05B | Caspase-8 Inhibitor | 5.0?mg |
| | Ac-Ile-Glu-Pro-Asp-pNA | 81-8-03 | Ac-Ile-Glu-Pro-Asp-pNA | 1.0?mg |
| | Ac-Ile-Glu-Thr-Asp-AMC | 81-6-23 | Caspase-3 Precursor Protease Substrates | 1.0?mg |
| | Ac-Ile-Glu-Thr-Asp-CHO | 81-3-00A | Ac-IETD-CHO | 1.0?mg |
| | Ac-Ile-Glu-Thr-Asp-CHO | 81-3-00B | Ac-IETD-CHO | 5.0?mg |
| | Ac-Ile-Tyr(PO3H2)-Gly-Glu-Phe-NH2 | 86-2-34A | P60c-src Substrate II, Phosphorylated | 0.5?mg |
| | Ac-Ile-Tyr(PO3H2)-Gly-Glu-Phe-NH2 | 86-2-34B | P60c-src Substrate II, Phosphorylated | 1.0?mg |
| | Ac-Ile-Tyr-Gly-Glu-Phe-NH2 | 86-2-33A | P60c-src Substrate II | 0.5?mg |
| | Ac-Ile-Tyr-Gly-Glu-Phe-NH2 | 86-2-33B | P60c-src Substrate II | 1.0?mg |
| | Ac-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Gln-Arg-Tyr-NH2 | 60-1-19A | Ac-[Leu28,31] Neuropeptide Y (24-36), human | 0.5?mg |
| | Ac-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Gln-Arg-Tyr-NH2 | 60-1-19B | Ac-[Leu28,31] Neuropeptide Y (24-36), human | 1.0?mg |
| | Ac-Leu-Glu-His-Asp-AMC | 81-9-00A | Caspase-9 Substrate | 1.0?mg |
| | Ac-Leu-Glu-His-Asp-AMC | 81-9-00B | Caspase-9 Substrate | 5.0?mg |
| | Ac-Leu-Glu-His-Asp-CHO | 81-4-00 | Ac-LEHD-CHO | 1.0?mg |
| | Ac-Leu-Glu-Val-Asp-CHO | 81-7-81A | Ac-Leu-Glu-Val-Asp-CHO | 1.0?mg |
| | Ac-Leu-Glu-Val-Asp-CHO | 81-7-81B | Ac-Leu-Glu-Val-Asp-CHO | 5.0?mg |
| | Ac-Leu-Leu-Arg-CHO | 81-5-70SA | Leupeptin (Synthetic) | 0.5?mg |
| | Ac-Leu-Leu-Arg-CHO | 81-5-70S-A | Leupeptin (Synthetic) | 0.5?mg |
| | Ac-Leu-Leu-Arg-CHO | 81-5-70SB | Leupeptin (Synthetic) | 1.0?mg |
| | Ac-Leu-Leu-Arg-CHO | 81-5-70S-B | Leupeptin (Synthetic) | 1.0?mg |
| | Ac-Leu-Leu-Met-CHO | 81-5-30 | Calpain Inhibitor II | 1.0?mg |
| | Ac-Leu-Leu-Nle-CHO | 81-5-10 | Ac-Leu-Leu-Norleucinal | 5.0?mg |
| | Ac-Leu-Leu-Nle-ol | 81-5-20 | Ac-Leu-Leu-Norleucinol | 5.0?mg |
| | Ac-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | 88-2-42A | BQ-3020 | 0.5?mg |
| | Ac-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | 88-2-42B | BQ-3020 | 1.0?mg |
| | Ac-Lys-Ala-Ser-Gln-Asn-Phe(NO2)-Pro-Val-Val-NH2 | 81-7-45A | HIV Protease Substrate I | 0.5?mg |
| | Ac-Lys-Ala-Ser-Gln-Asn-Phe(NO2)-Pro-Val-Val-NH2 | 81-7-45B | HIV Protease Substrate I | 1.0?mg |
| | Ac-Lys-Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-NH2 | 56-0-31A | Acetyl-(Lys0,Nle3)-g2-MSH amide | 0.5?mg |
| | Ac-Lys-Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-NH2 | 56-0-31B | Acetyl-(Lys0,Nle3)-g2-MSH amide | 1.0?mg |
| | Ac-Nle-c(-Asp-His-DTyr-Arg-Trp-Lys-NH2) | 56-0-30A | Acetyl-(Nle4,Asp5,DTyr7,Lys10)-cyclo-a-MSH (4-10) amide | 0.5?mg |
| | Ac-Nle-c(-Asp-His-DTyr-Arg-Trp-Lys-NH2) | 56-0-30B | Acetyl-(Nle4,Asp5,DTyr7,Lys10)-cyclo-a-MSH (4-10) amide | 1.0?mg |
| | Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 | 68-1-30A | (Ac-Nle4, Asp5, DPhe7, Lys10)-Cyclo-a-MSH (4-10) amide, MTII | 1.0?mg |
| | Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 | 68-1-30B | (Ac-Nle4, Asp5, DPhe7, Lys10)-Cyclo-a-MSH (4-10) amide, MTII | 5.0?mg |
| | Ac-Nle-Glu-His-DPhe-Arg-Trp-Gly-NH2 | 56-0-29 | N-Acetyl, [Nle4,DPhe7] a-MSH (4-10), amide | 1.0?mg |
| | Ac-Phe-Gly-pNA | 81-0-16A | Ac-Phe-Gly-pNA | 5.0?mg |
| | Ac-Phe-Gly-pNA | 81-0-16B | Ac-Phe-Gly-pNA | 25.0?mg |
| | Ac-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly-Lys-NH2 | 91-0-43 | Myelin Basic Protein, MBP (90-106) | 1.0?mg |
| | Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2 | 87-0-24A | Kallikrein Inhibitor | 1.0?mg |
| | Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2 | 87-0-24B | Kallikrein Inhibitor | 5.0?mg |
| | Ac-Pro-Tyr-Asn-Ser-Ser-Pro-Arg-Pro-Glu-Gln-His-Lys-Ser-Tyr-Lys-Cys | 91-1-25A | Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial Cell | 0.5?mg |
| | Ac-Pro-Tyr-Asn-Ser-Ser-Pro-Arg-Pro-Glu-Gln-His-Lys-Ser-Tyr-Lys-Cys | 91-1-25B | Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial Cell | 1.0?mg |
| | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn | 74-1-13A | Thymosin Alpha 1 | 0.5?mg |
| | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn | 74-1-13B | Thymosin Alpha 1 | 1.0?mg |
| | Ac-Ser-Asp-Lys-Pro | 87-0-25 | Ac-Ser-Asp-Lys-Pro | 5.0?mg |
| | Ac-Ser-Gln-Asn-Tyr | 72-2-40A | Ac-SQNY | 1.0?mg |
| | Ac-Ser-Gln-Asn-Tyr | 72-2-40B | Ac-SQNY | 5.0?mg |
| | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | 81-7-20A | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | 1.0?mg |
| | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | 81-7-20B | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | 5.0?mg |
| | Ac-Ser-Tyr-Ser-Met-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | 56-0-27 | [DPhe7] a-MSH, amide | 1.0?mg |
| | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val | 56-0-25 | a-MSH, Free Acid | 1.0?mg |
| | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly | 10-1-12A | Acetyl-ACTH (1-14) | 1.0?mg |
| | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly | 10-1-12B | Acetyl-ACTH (1-14) | 5.0?mg |
| | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg | 10-1-59A | N-Acetyl, ACTH (1-17), human | 0.5?mg |
| | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg | 10-1-59B | N-Acetyl, ACTH (1-17), human | 1.0?mg |
| | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | 56-1-11A | a-MSH, amide | 1.0?mg |
| | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | 56-1-11B | a-MSH, amide | 5.0?mg |
| | Ac-Ser-Tyr-Ser-Nle-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | 56-0-28 | [Nle4,DPhe7] a-MSH, amide | 1.0?mg |
| | Ac-Ser-Tyr-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | 56-0-26 | [Nle4] a-MSH, amide | 1.0?mg |
| | Ac-Thr-Lys-Arg-Arg-Ala-Ile-Gly-Phe-Lys-Lys-Leu-Ala-Glu-Ala-Val-Lys-Cys | 91-1-26A | Nitric Oxide Synthase (724-739) Blocking Peptide, Rat Brain | 0.5?mg |
| | Ac-Thr-Lys-Arg-Arg-Ala-Ile-Gly-Phe-Lys-Lys-Leu-Ala-Glu-Ala-Val-Lys-Cys | 91-1-26B | Nitric Oxide Synthase (724-739) Blocking Peptide, Rat Brain | 1.0?mg |
| | Ac-Trp-Glu-Ala-Asp-AMC | 81-7-21 | Ac-Trp-Glu-Ala-Asp-AMC | 1.0?mg |
| | Ac-Trp-Glu-Ala-Asp-pNA | 81-7-22 | Ac-Trp-Glu-Ala-Asp-pNA | 1.0?mg |
| | Ac-Trp-Glu-His-Asp-AMC | 81-7-18 | Ac-Trp-Glu-His-Asp-AMC | 1.0?mg |
| | Ac-Trp-Glu-His-Asp-CHO | 81-7-15A | Ac-WEHD-CHO | 1.0?mg |
| | Ac-Trp-Glu-His-Asp-CHO | 81-7-15B | Ac-WEHD-CHO | 5.0?mg |
| | Ac-Trp-Glu-His-Asp-pNA | 81-7-17 | Ac-Trp-Glu-His-Asp-pNA | 1.0?mg |
| | Ac-Trp-Val-Ala-Asp-AMC | 81-9-19 | Ac-Trp-Val-Ala-Asp-AMC | 1.0?mg |
| | Ac-Tyr-(NMe)Val-Ala-(NMe)Asp-CHO | 81-7-23A | Ac-Tyr-N-Me-Val-Ala-N-Me-Asp-CHO | 0.5?mg |
| | Ac-Tyr-(NMe)Val-Ala-(NMe)Asp-CHO | 81-7-23B | Ac-Tyr-N-Me-Val-Ala-N-Me-Asp-CHO | 1.0?mg |
| | Ac-Tyr-DArg-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | 52-1-69 | Ac-[DArg2] GHRF(1-29), amide, human | 1.0?mg |
| | Ac-Tyr-DPhe-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | 48-1-26 | [Tyr1,DPhe2] GHRF (1-29), N-Acetyl, amide | 1.0?mg |
| | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr | 28-4-31 | Acetyl, a-Endorphin | 1.0?mg |
| | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu | 28-0-41 | Acetyl, g-Endorphin | 1.0?mg |
| | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala | 28-1-36 | Acetyl, b-Endorphin (1-26), human | 1.0?mg |
| | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His | 28-6-29 | Ac, b-Endorphin (1-27), camel, bovine, ovine | 1.0?mg |
| | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | 28-6-23 | Acetyl, b-Endorphin, camel, bovine, ovine | 1.0?mg |
| | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr | 28-1-35 | Acetyl, b-Endorphin (1-27), human | 1.0?mg |
| | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | 28-1-14 | Acetyl, b-Endorphin, human | 1.0?mg |
| | Ac-Tyr-Val-Ala-Asp-2,6- dimethylbenzoyloxymethylketone | 81-7-16 | Ac-YVAD-2,6- dimethylbenzoyloxymethylketone | 1.0?mg |
| | Ac-Tyr-Val-Ala-Asp-AFC | 81-7-86 | Ac-Tyr-Val-Ala-Asp-AFC | 1.0?mg |
| | Ac-Tyr-Val-Ala-Asp-AMC | 81-7-30A | Ac-YVAD-AMC | 1.0?mg |
| | Ac-Tyr-Val-Ala-Asp-AMC | 81-7-30B | Ac-YVAD-AMC | 5.0?mg |
| | Ac-Tyr-Val-Ala-Asp-CHO | 81-7-31A | Ac-YVAD-CHO | 1.0?mg |
| | Ac-Tyr-Val-Ala-Asp-CHO | 81-7-31B | Ac-YVAD-CHO | 5.0?mg |
| | Ac-Tyr-Val-Ala-Asp-CMK | 81-7-35A | Ac-YVKD-CMK | 0.5?mg |
| | Ac-Tyr-Val-Ala-Asp-CMK | 81-7-35B | Ac-YVKD-CMK | 1.0?mg |
| | Ac-Tyr-Val-Ala-Asp-fluoroacyloxymethylketone | 81-7-32A | ICE Inhibitor III | 0.5?mg |
| | Ac-Tyr-Val-Ala-Asp-fluoroacyloxymethylketone | 81-7-32B | ICE Inhibitor III | 1.0?mg |
| | Ac-Tyr-Val-Ala-Asp-pNA | 81-7-34 | Ac-YVAD-pNA | 1.0?mg |
| | Ac-Tyr-Val-Lys(Biotin)-Asp-2,6-dimethylbenzoyloxymethylketone | 81-7-08A | Ac-Tyr-Val-Lys(biotinyl)-Asp-2,6-dimethylbenzoyloxymethylketone | 0.5?mg |
| | Ac-Tyr-Val-Lys(Biotin)-Asp-2,6-dimethylbenzoyloxymethylketone | 81-7-08B | Ac-Tyr-Val-Lys(biotinyl)-Asp-2,6-dimethylbenzoyloxymethylketone | 1.0?mg |
| | Ac-Tyr-Val-Lys-Asp-CHO | 81-7-01 | IL-1b Converting Enzyme (ICE) Inhibitor IV | 1.0?mg |
| | Ac-Val-Ala-Asp-CHO | 81-7-02A | Ac-VAD-CHO | 1.0?mg |
| | Ac-Val-Ala-Asp-CHO | 81-7-02B | Ac-VAD-CHO | 5.0?mg |
| | Ac-Val-Ala-Asp-CMK | 81-7-03A | Ac-VAD-CMK | 1.0?mg |
| | Ac-Val-Ala-Asp-CMK | 81-7-03B | Ac-VAD-CMK | 5.0?mg |
| | Ac-Val-Asp-Val-Ala-Asp-CHO | 81-7-75 | Ac-VDVAD-CHO | 1.0?mg |
| | Ac-Val-Asp-Val-Ala-Asp-pNA | 81-7-76 | Ac-Val-Asp-Val-Ala-Asp-pNA | 1.0?mg |
| | Ac-Val-Glu-His-Asp-AFC | 81-7-84 | Ac-Val-Glu-His-Asp-AFC | 1.0?mg |
| | Ac-Val-Glu-Ile-Asp-AMC | 81-9-20 | Ac-Val-Glu-Ile-Asp-AMC | 1.0?mg |
| | Ac-Val-Glu-Ile-Asp-CHO | 81-7-04A | Ac-VEID-CHO | 1.0?mg |
| | Ac-Val-Glu-Ile-Asp-CHO | 81-7-04B | Ac-VEID-CHO | 5.0?mg |
| | Ac-Val-Glu-Ile-Asp-pNA | 81-9-21 | Ac-Val-Glu-Ile-Asp-pNA | 1.0?mg |
| | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | 30-0-72A | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | 1.0?mg |
| | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | 30-0-72B | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | 5.0?mg |
| | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met | 30-0-34A | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met | 1.0?mg |
| | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met | 30-0-34B | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met | 5.0?mg |
| | Ala-Ala-Gly-Met-Gly-Phe-Phe-Gly-Ala-Arg-NH2 | 87-7-55A | Urechistachykinin II | 0.5?mg |
| | Ala-Ala-Gly-Met-Gly-Phe-Phe-Gly-Ala-Arg-NH2 | 87-7-55B | Urechistachykinin II | 1.0?mg |
| | Ala-Ala-Phe-CMK | 81-4-56 | Ala-Ala-Phe-chloromethylketone ¡¤ TFA | 5.0?mg |
| | Ala-Ala-Pro-Val-CMK | 81-4-57 | Ala-Ala-Pro-Val-chloromethylketone | 5.0?mg |
| | Ala-Arg-Arg-Pro-Glu-Gly-Arg-Thr-Trp-Ala-Gln-Pro-Gly-Tyr | 86-5-17A | Ala-Arg-Arg-Pro-Glu-Gly-Arg-Thr-Trp-Ala-Gln-Pro-Gly-Tyr | 0.5?mg |
| | Ala-Arg-Arg-Pro-Glu-Gly-Arg-Thr-Trp-Ala-Gln-Pro-Gly-Tyr | 86-5-17B | Ala-Arg-Arg-Pro-Glu-Gly-Arg-Thr-Trp-Ala-Gln-Pro-Gly-Tyr | 1.0?mg |
| | Ala-Arg-Leu-Asp-Thr-Ser-Ser-Gln-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | 22-8-20A | Pro-Adrenomedullin (N-20), rat | 0.5?mg |
| | Ala-Arg-Leu-Asp-Thr-Ser-Ser-Gln-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | 22-8-20B | Pro-Adrenomedullin (N-20), rat | 1.0?mg |
| | Ala-Arg-Leu-Asp-Val-Ala-Ala-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | 22-3-11A | Pro-Adrenomedullin (N-20), porcine | 0.5?mg |
| | Ala-Arg-Leu-Asp-Val-Ala-Ala-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | 22-3-11B | Pro-Adrenomedullin (N-20), porcine | 1.0?mg |
| | Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | 22-1-19A | Pro-Adrenomedullin (N-20), human | 0.5?mg |
| | Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | 22-1-19B | Pro-Adrenomedullin (N-20), human | 1.0?mg |
| | Ala-Arg-Pro-Gly-Tyr-Leu-Ala-Phe-Pro-Arg-Met-NH2 | 60-0-60A | SCPA | 1.0?mg |
| | Ala-Arg-Pro-Gly-Tyr-Leu-Ala-Phe-Pro-Arg-Met-NH2 | 60-0-60B | SCPA | 5.0?mg |
| | Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | 60-4-25A | Neuropeptide Y (18-36), porcine | 0.5?mg |
| | Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | 60-4-25B | Neuropeptide Y (18-36), porcine | 1.0?mg |
| | Ala-Asp-Ala-Gln-His-Ala-Thr-Pro-Pro-Lys-Lys-Lys-Arg-Lys-Val-Glu-Asp-Pro-Lys-Asp-Phe | 86-0-12A | P34cdc2 Kinase Substrate Peptide | 0.5?mg |
| | Ala-Asp-Ala-Gln-His-Ala-Thr-Pro-Pro-Lys-Lys-Lys-Arg-Lys-Val-Glu-Asp-Pro-Lys-Asp-Phe | 86-0-12B | P34cdc2 Kinase Substrate Peptide | 1.0?mg |
| | Ala-Asp-Leu-Met-Gly-Tyr-Ile-Pro-Leu-Val | 72-3-51A | HCV Peptide Aa:131-140 | 0.5?mg |
| | Ala-Asp-Leu-Met-Gly-Tyr-Ile-Pro-Leu-Val | 72-3-51B | HCV Peptide Aa:131-140 | 1.0?mg |
| | Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | 22-1-57 | Parathyroid Hormone (70-84), human | 1.0?mg |
| | Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg | 42-1-12A | Fibrinopeptide A, human | 1.0?mg |
| | Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg | 42-1-12B | Fibrinopeptide A, human | 5.0?mg |
| | Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Asp-Phe-Leu-Ser-Arg-Ser-Gly-Gly-Val-Gly-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | 22-7-10A | Calcitonin Gene Related Peptide, chicken | 0.5?mg |
| | Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Asp-Phe-Leu-Ser-Arg-Ser-Gly-Gly-Val-Gly-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | 22-7-10B | Calcitonin Gene Related Peptide, chicken | 1.0?mg |
| | Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | 22-1-14A | Calcitonin Gene Related Peptide II, human | 0.5?mg |
| | Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | 22-1-14B | Calcitonin Gene Related Peptide II, human | 1.0?mg |
| | Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser | 22-5-16A | Calcitonin Gene Related Peptide (1-19), human | 0.5?mg |
| | Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser | 22-5-16B | Calcitonin Gene Related Peptide (1-19), human | 1.0?mg |
| | Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | 22-1-12A | Calcitonin Gene Related Peptide, human | 0.5?mg |
| | Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | 22-1-12B | Calcitonin Gene Related Peptide, human | 1.0?mg |
| | Ala-Cys-Ser-Gly-Arg-Gly-Ser-Arg-Cys-Hyp-Hyp-Gln-Cys-Cys-Met-Gly-Leu-Arg-Cys-Gly-Arg-Gly-Asn-Pro-Gln-Lys-Cys-Ile-Gly-Ala-His-Gla-Asp-Val | 41-0-76 | m-Conotoxin GS | 0.1?mg |
| | Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys | 72-2-10 | Defensin-1 (human) HNP-1 | 0.1?mg |
| | Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | 46-1-22A | Glucagon (19-29), human | 1.0?mg |
| | Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | 46-1-22B | Glucagon (19-29), human | 5.0?mg |
| | Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | 56-1-32 | b-MSH, human | 1.0?mg |
| | Ala-Gly-Asn-Lys-Val-Ile-Ser-Pro-Ser-Glu-Asp-Arg-Arg-Gln-Cys | 86-1-10A | Protein Kinase C (alpha) Peptide | 0.5?mg |
| | Ala-Gly-Asn-Lys-Val-Ile-Ser-Pro-Ser-Glu-Asp-Arg-Arg-Gln-Cys | 86-1-10B | Protein Kinase C (alpha) Peptide | 1.0?mg |
| | Ala-Gly-Asp-Val | 44-0-11 | A-G-D-V | 5.0?mg |
| | Ala-Gly-Cys-Lys-Asn-Phe-Phe-DTrp-Lys-Thr-Phe-Thr-Ser-Cys | 68-1-22 | [DTrp8] Somatostatin | 1.0?mg |
| | Ala-Gly-Cys-Lys-Asn-Phe-Phe-DTrp-Lys-Thr-Phe-Thr-Ser-DCys | 68-1-33 | [DTrp8,DCys14] Somatostatin | 1.0?mg |
| | Ala-Gly-Cys-Lys-Asn-Phe-Phe-DTrp-Lys-Thr-Tyr-Thr-Ser-Cys | 68-1-37 | [DTrp8,Tyr11] Somatostatin | 1.0?mg |
| | Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys | 68-1-10 | Somatostatin | 5.0?mg |
| | Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser-Cys | 68-1-14 | [Tyr11] Somatostatin | 1.0?mg |
| | Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2 | 32-3-13A | A-18-F-NH2; Morphine Modulating Neuropeptide | 0.5?mg |
| | Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2 | 32-3-13B | A-18-F-NH2; Morphine Modulating Neuropeptide | 1.0?mg |
| | Ala-Gly-Ser-Glu | 40-0-64 | Eosinophilotactic Peptide | 5.0?mg |
| | Ala-Gly-Thr-Ala-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val | 80-7-30 | Urotensin II , goby | 1.0?mg |
| | Ala-Leu-Ala-Leu | 82-2-05 | Ala-Leu-Ala-Leu | 1.0?mg |
| | Ala-Leu-Asn-Ser-Val-Ala-Tyr-Glu-Arg-Ser-Ala-Met-Gln-Asn-Tyr-Glu-Arg-Arg-Arg | 87-7-70A | Tachykinin (111-129) Beta-Prepro (Human) | 0.5?mg |
| | Ala-Leu-Asn-Ser-Val-Ala-Tyr-Glu-Arg-Ser-Ala-Met-Gln-Asn-Tyr-Glu-Arg-Arg-Arg | 87-7-70B | Tachykinin (111-129) Beta-Prepro (Human) | 1.0?mg |
| | Ala-Leu-Leu-Glu-Thr-Tyr-Cys-Ala-Thr-Pro-Ala-Lys-Ser-Glu | 50-1-22 | Insulin-Like Growth Factor I (57-70) | 1.0?mg |
| | Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Ala-Leu-Gly-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln | 79-4-15A | Dermaseptin | 0.5?mg |
| | Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Ala-Leu-Gly-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln | 79-4-15B | Dermaseptin | 1.0?mg |
| | Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2 | 62-7-70 | Scyliorhinin I, amide, dogfish | 1.0?mg |
| | Ala-Met-Pro-Met-Leu-Arg-Leu-NH2 | 62-7-16A | Catch-Relaxing Peptide (CARP) | 0.5?mg |
| | Ala-Met-Pro-Met-Leu-Arg-Leu-NH2 | 62-7-16B | Catch-Relaxing Peptide (CARP) | 1.0?mg |
| | Ala-Phe-Cys-Asn-Leu-Arg-Met-Cys-Gln-Leu-Ser-Cys-Arg-Ser-Leu-Gly-Leu-Leu-Gly-Lys-Cys-Ile-Gly-Asp-Lys-Cys-Glu-Cys-Val-Lys-His-NH2 | 41-0-24A | Scyllatoxin | 0.1?mg |
| | Ala-Phe-Leu-Pro-Trp-His-Arg-Leu-Phe | 81-0-18A | Tyrosinase (206-214), human | 0.5?mg |
| | Ala-Phe-Leu-Pro-Trp-His-Arg-Leu-Phe | 81-0-18B | Tyrosinase (206-214), human | 1.0?mg |
| | Ala-Phe-Pro-Leu-Glu-Phe | 10-1-38A | ACTH (34-39) | 1.0?mg |
| | Ala-Phe-Pro-Leu-Glu-Phe | 10-1-38B | ACTH (34-39) | 5.0?mg |
| | Ala-Pro-Arg-Leu-Arg-Phe-Tyr | 87-0-94 | a-Bag Cell Peptide (1-7) | 1.0?mg |
| | Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser | 87-0-93 | a-Bag Cell Peptide (1-8) | 1.0?mg |
| | Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser-Leu | 87-0-92 | a-Bag Cell Peptide (1-9) | 1.0?mg |
| | Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu | 41-0-74A | Decorsin, Leech | 0.01?mg |
| | Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu | 41-0-74B | Decorsin, Leech | 0.1?mg |
| | Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu | 41-0-75A | [Des Asp10]Decorsin, Leech | 0.01?mg |
| | Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu | 41-0-75B | [Des Asp10]Decorsin, Leech | 0.1?mg |
| | Ala-Pro-Arg-Ser-Met-Arg-Arg-Ser-Ser-Asp-Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Phe | 14-7-25A | ANP (1-30), frog | 0.5?mg |
| | Ala-Pro-Arg-Ser-Met-Arg-Arg-Ser-Ser-Asp-Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Phe | 14-7-25B | ANP (1-30), frog | 1.0?mg |
| | Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | 91-0-45 | Myelin Basic Protein (95-98) S5 Peptide MAP Kinase Substrate | 1.0?mg |
| | Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | 91-0-45A | Myelin Basic Protein (95-98) S5 Peptide MAP Kinase Substrate | 1.0?mg |
| | Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | 91-0-45B | Myelin Basic Protein (95-98) S5 Peptide MAP Kinase Substrate | 5.0?mg |
| | Ala-Pro-Gly-Asp-Arg-Ile-Tyr-Val-His-Pro-Phe | 12-1-60A | [Ala-Pro-Gly-(Ile3,Val5)] Angiotensin II | 5.0?mg |
| | Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly | 22-1-35A | Parathyroid Hormone (39-68), human | 0.5?mg |
| | Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly | 22-1-35B | Parathyroid Hormone (39-68), human | 1.0?mg |
| | Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | 22-1-40A | Parathyroid Hormone (39-84), human | 0.5?mg |
| | Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | 22-1-40B | Parathyroid Hormone (39-84), human | 1.0?mg |
| | Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | 46-5-20A | Pancreatic Polypeptide, rat | 0.5?mg |
| | Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | 46-5-20B | Pancreatic Polypeptide, rat | 1.0?mg |
| | Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 | 60-1-26A | Pancreatic Polypeptide Fragment 1-17-[Ala31, alpha-Aminoisobutryl32]-Neuropeptide Y Fragment 18-36 | 0.5?mg |
| | Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 | 60-1-26B | Pancreatic Polypeptide Fragment 1-17-[Ala31, alpha-Aminoisobutryl32]-Neuropeptide Y Fragment 18-36 | 1.0?mg |
| | Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | 46-1-69A | Pancreatic Polypeptide, human | 0.5?mg |
| | Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | 46-1-69B | Pancreatic Polypeptide, human | 1.0?mg |
| | Ala-Pro-Leu-Ser-Gly-Phe-Tyr-Gly-Val-Arg-NH2 | 87-7-65A | Locustachykinin II | 0.5?mg |
| | Ala-Pro-Leu-Ser-Gly-Phe-Tyr-Gly-Val-Arg-NH2 | 87-7-65B | Locustachykinin II | 1.0?mg |
| | Ala-Pro-Phe-Arg-Ser-Ala-Leu-Glu-Ser-Ser-Pro-Ala-Asp-Pro-Ala-Thr-Leu-Ser-Glu-Asp-Glu-Ala-Arg-Leu-Leu-Leu-Ala-Ala-Leu-Val-Gln-Asp-Tyr-Val-Gln-Met-Lys-Ala-Ser-Glu-Leu-Glu-Gln-Glu-Gln-Glu-Arg-Glu-Gly-Ser-Ser-Leu-Asp-Ser-Pro-Arg-Ser | 22-2-30 | N-proCT Amino-terminal Procalcitonin | 0.1?mg |
| | Ala-Pro-Ser-Asp-Pro-Arg-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Ala-Gly-Lys-Gln-Glu-Leu-Ala-Lys-Tyr-Phe-Leu-Ala-Glu-Leu | 68-1-68A | Prosomatostatin (1-32), porcine | 0.5?mg |
| | Ala-Pro-Ser-Asp-Pro-Arg-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Ala-Gly-Lys-Gln-Glu-Leu-Ala-Lys-Tyr-Phe-Leu-Ala-Glu-Leu | 68-1-68B | Prosomatostatin (1-32), porcine | 1.0?mg |
| | Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2 | 87-7-10A | Allatostatin I | 1.0?mg |
| | Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2 | 87-7-10B | Allatostatin I | 5.0?mg |
| | Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro | 46-4-34 | Gastrin Releasing Peptide (1-16), porcine | 1.0?mg |
| | Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | 46-4-40A | Gastrin Releasing Peptide, porcine | 0.5?mg |
| | Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | 46-4-40B | Gastrin Releasing Peptide, porcine | 1.0?mg |
| | Ala-Ser-Ala-Ser-Ser-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | 88-1-11A | [Ala1,3,11,15] Endothelin-1, human | 0.5?mg |
| | Ala-Ser-Ala-Ser-Ser-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | 88-1-11B | [Ala1,3,11,15] Endothelin-1, human | 1.0?mg |
| | Ala-Ser-Thr-Thr-Thr-Asn-(3,5 diiodo)Tyr-Thr | 72-2-30A | [3,5 Diiodo-Tyr7] Peptide T | 1.0?mg |
| | Ala-Ser-Thr-Thr-Thr-Asn-(3,5 diiodo)Tyr-Thr | 72-2-30B | [3,5 Diiodo-Tyr7] Peptide T | 5.0?mg |
| | Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr | 72-2-16A | Peptide T | 1.0?mg |
| | Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr | 72-2-16B | Peptide T | 5.0?mg |
| | Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | 74-5-13A | Amylin (8-37), rat | 0.5?mg |
| | Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | 74-5-13B | Amylin (8-37), rat | 1.0?mg |
| | Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr | 74-5-16A | Amylin (8-37), human | 0.5?mg |
| | Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr | 74-5-16B | Amylin (8-37), human | 1.0?mg |
| | Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr | 74-5-17A | Amylin (8-37), Human (Free Acid) | 0.5?mg |
| | Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr | 74-5-17B | Amylin (8-37), Human (Free Acid) | 1.0?mg |
| | Ala-Thr-Leu-Asn-Phe-Pro-Ile-Ser-Pro-Trp | 72-3-70A | HIV-1, HIV-2 Protease Substrate | 1.0?mg |
| | Ala-Thr-Leu-Asn-Phe-Pro-Ile-Ser-Pro-Trp | 72-3-70B | HIV-1, HIV-2 Protease Substrate | 5.0?mg |
| | Ala-Val-Gln-Ser-Lys-Pro-Pro-Ser-Lys-Arg-Asp-Pro-Pro-Lys-Met-Gln-Thr-Asp | 79-3-10A | Systemin | 0.5?mg |
| | Ala-Val-Gln-Ser-Lys-Pro-Pro-Ser-Lys-Arg-Asp-Pro-Pro-Lys-Met-Gln-Thr-Asp | 79-3-10B | Systemin | 1.0?mg |
| | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala | 22-1-74A | Hypercalcemia Malignancy Factor (1-34), human | 0.5?mg |
| | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala | 22-1-74B | Hypercalcemia Malignancy Factor (1-34), human | 1.0?mg |
| | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser | 22-1-70A | Hypercalcemia Malignancy Factor (1-40) | 0.5?mg |
| | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser | 22-1-70B | Hypercalcemia Malignancy Factor (1-40) | 1.0?mg |
| | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | 22-1-71A | Hypercalcemia Malignancy Factor (1-34), amide, human | 0.5?mg |
| | Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | 22-1-71B | Hypercalcemia Malignancy Factor (1-34), amide, human | 1.0?mg |
| | Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | 22-5-21A | Parathyroid Hormone (1-34), rat | 0.5?mg |
| | Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | 22-5-21B | Parathyroid Hormone (1-34), rat | 1.0?mg |
| | Ala-Val-Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Nle-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2 | 22-5-25A | [Nle8,21,Tyr34] Parathyroid Hormone (1-34), amide, rat | 0.5?mg |
| | Ala-Val-Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Nle-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2 | 22-5-25B | [Nle8,21,Tyr34] Parathyroid Hormone (1-34), amide, rat | 1.0?mg |
| | Ala-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | 22-3-15A | Parathyroid Hormone (1-34), bovine | 0.5?mg |
| | Ala-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | 22-3-15B | Parathyroid Hormone (1-34), bovine | 1.0?mg |
| | Arg-(Dehydro)Pro-Lys-(Dehydro)Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met-NH2 | 70-9-30 | [(Dehydro)Pro2,4, Pro9]-Substance P | 1.0?mg |
| | Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp | 86-2-27A | RRRDDDSDDD | 0.5?mg |
| | Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp | 86-2-27B | RRRDDDSDDD | 1.0?mg |
| | Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu | 86-2-25A | Casein Kinase II Substrate | 0.5?mg |
| | Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu | 86-2-25B | Casein Kinase II Substrate | 1.0?mg |
| | Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg | 20-1-15A | Proinsulin C-Peptide (55-89), human | 0.5?mg |
| | Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg | 20-1-15B | Proinsulin C-Peptide (55-89), human | 1.0?mg |
| | Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg | 20-1-15B | Proinsulin C-Peptide (55-89), Human | 1.0?mg |
| | Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu | 86-2-26A | RREEETEEE | 0.5?mg |
| | Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu | 86-2-26B | RREEETEEE | 1.0?mg |
| | Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | 26-4-30 | Dynorphin A (6-17), porcine | 1.0?mg |
| | Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly | 86-0-53A | RR-SRC | 0.5?mg |
| | Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly | 86-0-53B | RR-SRC | 1.0?mg |
| | Arg-Arg-Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gly | 86-0-10A | Substrate for Tyrosine Protein Kinase | 0.5?mg |
| | Arg-Arg-Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gly | 86-0-10B | Substrate for Tyrosine Protein Kinase | 1.0?mg |
| | Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala | 86-2-35A | S6-1 | 1.0?mg |
| | Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala | 86-2-35B | S6-1 | 5.0?mg |
| | Arg-Arg-Lys-Ala-Ser-Gly-Pro | 86-0-11A | RRKASGP | 1.0?mg |
| | Arg-Arg-Lys-Ala-Ser-Gly-Pro | 86-0-11B | RRKASGP | 5.0?mg |
| | Arg-Arg-Lys-Ala-Ser-Gly-Pro-Pro-Val | 86-5-40A | Phosphate Acceptor Peptide | 1.0?mg |
| | Arg-Arg-Lys-Ala-Ser-Gly-Pro-Pro-Val | 86-5-40B | Phosphate Acceptor Peptide | 5.0?mg |
| | Arg-Arg-Pro-Trp-Ile-Leu | 62-1-12 | [Trp11] Neurotensin (8-13) | 1.0?mg |
| | Arg-Arg-Pro-Tyr-Ile-Leu | 62-1-24 | Neurotensin (8-13) | 1.0?mg |
| | Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr | 14-5-44A | ANP (3-28), rat | 0.5?mg |
| | Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr | 14-5-44B | ANP (3-28), rat | 1.0?mg |
| | Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr | 14-1-18A | Atrial Natriuretic Peptide (3-28), human | 0.5?mg |
| | Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr | 14-1-18B | Atrial Natriuretic Peptide (3-28), human | 1.0?mg |
| | Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly | 72-1-31A | Lactoferricin, bovine, (BLFC) | 0.5?mg |
| | Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly | 72-1-31B | Lactoferricin, bovine, (BLFC) | 1.0?mg |
| | Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly | 22-1-42A | Parathyroid Hormone (44-68), human | 0.5?mg |
| | Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly | 22-1-42B | Parathyroid Hormone (44-68), human | 1.0?mg |
| | Arg-Asp-Cys-Cys-Thr-Hyp-Hyp-Lys-Lys-Cys-Lys-Asp-Arg-Gln-Cys-Lys-Hyp-Gln-Arg-Cys-Cys-Ala-NH2 | 41-0-50 | m-Conotoxin GIIIA | 0.1?mg |
| | Arg-Asp-Hyp-Cys-Cys-Tyr-His-Pro-Thr-Cys-Asn-Met-Ser-Asn-Pro-Gln-Ile-Cys | 41-0-80 | a-Conotoxin El, Conus ermineus | 0.1?mg |
| | Arg-Asp-Tyr(SO3H)-Thr-Gly-Trp-Nle-Asp-Phe-NH2 | 46-1-07A | (Thr28,Nle31)-Cholecystokinin-33 (25-33) (sulfated) | 0.5?mg |
| | Arg-Asp-Tyr(SO3H)-Thr-Gly-Trp-Nle-Asp-Phe-NH2 | 46-1-07B | (Thr28,Nle31)-Cholecystokinin-33 (25-33) (sulfated) | 1.0?mg |
| | Arg-DPro-Lys-Pro-Gln-Gln-DPhe-Phe-DTrp-Leu-Met-NH2 | 70-1-92 | [DPro2,DPhe7,DTrp9] Substance P | 1.0?mg |
| | Arg-DPro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2 | 70-9-23 | [DPro2,DTrp7,9] Substance P | 1.0?mg |
| | Arg-DTrp-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2 | 70-1-95A | [DTrp2,7,9] Substance P | 1.0?mg |
| | Arg-DTrp-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2 | 70-1-95B | [DTrp2,7,9] Substance P | 5.0?mg |
| | Arg-DTrp-NMe-Phe-DTrp-Leu-Met-NH2 | 70-9-32A | Antagonist G | 0.5?mg |
| | Arg-DTrp-NMe-Phe-DTrp-Leu-Met-NH2 | 70-9-32B | Antagonist G | 1.0?mg |
| | Arg-Glu(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(DABCYL)-Arg | 81-3-20A | Arg-Glu(EDANS)-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (668-675)-Lys(DABCYL)-Arg | 0.5?mg |
| | Arg-Glu(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(DABCYL)-Arg | 81-3-20B | Arg-Glu(EDANS)-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (668-675)-Lys(DABCYL)-Arg | 1.0?mg |
| | Arg-Glu-(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(DABCYL)-Arg | 81-1-02A | Arg-Glu-(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(DABCYL)-Arg | 0.5?mg |
| | Arg-Glu-(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(DABCYL)-Arg | 81-1-02B | Arg-Glu-(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(DABCYL)-Arg | 1.0?mg |
| | Arg-Glu-Arg-Met-Ser | 62-5-15A | ß-Amyloid / A4 Protein Precursor (APP) (328-332) | 0.5?mg |
| | Arg-Glu-Arg-Met-Ser | 62-5-15B | ß-Amyloid / A4 Protein Precursor (APP) (328-332) | 1.0?mg |
| | Arg-Glu-Asp-Val | 44-0-12 | R-E-D-V | 5.0?mg |
| | Arg-Gly-Arg-Arg-Gln-Pro-Ile-Pro-Lys-Ala | 72-3-33A | HCV Core Protein (59-68) | 0.5?mg |
| | Arg-Gly-Arg-Arg-Gln-Pro-Ile-Pro-Lys-Ala | 72-3-33B | HCV Core Protein (59-68) | 1.0?mg |
| | Arg-Gly-Asp-Cys | 44-0-13 | R-G-D-C | 5.0?mg |
| | Arg-Gly-Asp-Ser | 44-0-14 | R-G-D-S | 5.0?mg |
| | Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro | 44-0-15 | R-G-D-S-P-A-S-S-K-P | 1.0?mg |
| | Arg-Gly-Asp-Thr | 44-0-16 | R-G-D-T | 5.0?mg |
| | Arg-Gly-Asp-Val | 44-0-17 | R-G-D-V | 5.0?mg |
| | Arg-Gly-Glu-Ser | 44-0-18 | R-G-E-S | 5.0?mg |
| | Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile | 72-3-34A | HIV (gp120) (318-327) | 0.5?mg |
| | Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile | 72-3-34B | HIV (gp120) (318-327) | 1.0?mg |
| | Arg-Gly-Tyr-Ala-Leu-Gly | 86-0-52A | Arg-Gly-Tyr-Ala-Leu-Gly | 1.0?mg |
| | Arg-Gly-Tyr-Ala-Leu-Gly | 86-0-52B | Arg-Gly-Tyr-Ala-Leu-Gly | 5.0?mg |
| | Arg-Gly-Tyr-Ser-Leu-Gly | 86-0-51A | Arg-Gly-Tyr-Ser-Leu-Gly | 1.0?mg |
| | Arg-Gly-Tyr-Ser-Leu-Gly | 86-0-51B | Arg-Gly-Tyr-Ser-Leu-Gly | 5.0?mg |
| | Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | 26-4-31 | Dynorphin A (7-17), porcine | 1.0?mg |
| | Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys | 72-2-39A | R15K, HIV-1 Inhibitory Peptide | 0.5?mg |
| | Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys | 72-2-39B | R15K, HIV-1 Inhibitory Peptide | 1.0?mg |
| | Arg-Leu-Arg-Phe-Asp | 88-0-96 | g-Bag Cell Factor | 1.0?mg |
| | Arg-Leu-Arg-Phe-His | 88-0-95 | b-Bag Cell Factor | 1.0?mg |
| | Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg | 73-3-10A | Bactenecin, bovine | 1.0?mg |
| | Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg | 73-3-10B | Bactenecin, bovine | 5.0?mg |
| | Arg-Lys-Arg-Ala-Arg-Lys-Glu | 86-0-56A | Arg-Lys-Arg-Ala-Arg-Lys-Glu | 1.0?mg |
| | Arg-Lys-Arg-Ala-Arg-Lys-Glu | 86-0-56B | Arg-Lys-Arg-Ala-Arg-Lys-Glu | 5.0?mg |
| | Arg-Lys-Arg-Ser-Arg-Ala-Glu | 86-0-59A | Arg-Lys-Arg-Ser-Arg-Ala-Glu | 1.0?mg |
| | Arg-Lys-Arg-Ser-Arg-Ala-Glu | 86-0-59B | Arg-Lys-Arg-Ser-Arg-Ala-Glu | 5.0?mg |
| | Arg-Lys-Arg-Ser-Arg-Lys-Glu | 86-0-55A | Arg-Lys-Arg-Ser-Arg-Lys-Glu | 1.0?mg |
| | Arg-Lys-Arg-Ser-Arg-Lys-Glu | 86-0-55B | Arg-Lys-Arg-Ser-Arg-Lys-Glu | 5.0?mg |
| | Arg-Lys-Asp | 87-0-21A | Thymopoietin II (32-34) | 5.0?mg |
| | Arg-Lys-Asp | 87-0-21B | Thymopoietin II (32-34) | 100.0?mg |
| | Arg-Lys-Asp-Val | 87-0-19A | Thymopoietin II (32-35) | 5.0?mg |
| | Arg-Lys-Asp-Val | 87-0-19B | Thymopoietin II (32-35) | 100.0?mg |
| | Arg-Lys-Asp-Val-Tyr | 87-0-22A | Thymopentin | 5.0?mg |
| | Arg-Lys-Asp-Val-Tyr | 87-0-22B | Thymopentin | 100.0?mg |
| | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys | 86-1-20A | Protein Kinase C (19-35) Peptide | 0.5?mg |
| | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys | 86-1-20B | Protein Kinase C (19-35) Peptide | 1.0?mg |
| | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | 86-1-25A | Protein Kinase C (19-36) Peptide | 0.5?mg |
| | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | 86-1-25B | Protein Kinase C (19-36) Peptide | 1.0?mg |
| | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Glu-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | 86-0-22A | [Glu27] Protein Kinase C (19-36) | 0.5?mg |
| | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Glu-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | 86-0-22B | [Glu27] Protein Kinase C (19-36) | 1.0?mg |
| | Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val | 86-0-33A | [Ser25] Protein Kinase C (19-31) | 0.5?mg |
| | Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val | 86-0-33B | [Ser25] Protein Kinase C (19-31) | 1.0?mg |
| | Arg-Phe-Ala-Val-Arg-Asp-Met-Arg-Gln-Thr-Val-Ala-Val-Gly-Val-Ile-Lys-Ala-Val-Asp-Lys-Lys | 1986-1-17A | Protein Kinase C|A Peptide Substrate | 0.5?mg |
| | Arg-Phe-Ala-Val-Arg-Asp-Met-Arg-Gln-Thr-Val-Ala-Val-Gly-Val-Ile-Lys-Ala-Val-Asp-Lys-Lys | 1986-1-17B | Protein Kinase C|A Peptide Substrate | 1.0?mg |
| | Arg-Phe-Ala-Val-Arg-Asp-Met-Arg-Gln-Thr-Val-Ala-Val-Gly-Val-Ile-Lys-Ala-Val-Asp-Lys-Lys | 86-1-17A | Protein Kinase C|A Peptide Substrate | 0.5?mg |
| | Arg-Phe-Ala-Val-Arg-Asp-Met-Arg-Gln-Thr-Val-Ala-Val-Gly-Val-Ile-Lys-Ala-Val-Asp-Lys-Lys | 86-1-17B | Protein Kinase C|A Peptide Substrate | 1.0?mg |
| | Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | 12-1-17A | Apelin-12, human, bovine, mouse, rat | 0.5?mg |
| | Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | 12-1-17B | Apelin-12, human, bovine, mouse, rat | 1.0?mg |
| | Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | 70-1-32 | [Arg3] Substance P | 1.0?mg |
| | Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg | 12-1-87 | Angiotensin I Converting Enzyme Inhibitor | 5.0?mg |
| | Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | 46-2-72A | Orexin B, rat, mouse | 0.5?mg |
| | Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | 46-2-72B | Orexin B, rat, mouse | 1.0?mg |
| | Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | 46-2-73A | Orexin B, canine | 0.5?mg |
| | Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | 46-2-73B | Orexin B, canine | 1.0?mg |
| | Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | 26-4-46 | Dynorphin A (9-17), porcine | 1.0?mg |
| | Arg-Pro-Lys-Pro | 70-1-85 | Substance P (1-4) | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe | 70-1-83 | Substance P (1-7) | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-(NMe)Phe-Sar-Leu-Met-NH2 | 70-1-30 | [MePhe8,Sar9] Substance P | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe(pNO2)-Phe-Gly-Leu-Nle-NH2 | 70-9-11A | [(pNO2)Phe7,Nle11] Substance P | 0.5?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe(pNO2)-Phe-Gly-Leu-Nle-NH2 | 70-9-11B | [(pNO2)Phe7,Nle11] Substance P | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly | 70-1-80 | Substance P (1-9) | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Gly-NH2 | 70-1-79 | [Gly11] Substance P | 5.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-His-NH2 | 70-1-74 | [His11]Substance P | 5.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met | 70-1-13 | Substance P, Free Acid | 5.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Gly-Lys-Arg | 70-1-38 | Substance P-Gly-Lys-Arg | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | 70-1-10 | Substance P | 5.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-OMe | 70-1-27 | Substance P Methyl ester | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Nle-NH2 | 70-1-21 | [Nle11] Substance P | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met-NH2 | 70-1-31A | [Pro9] Substance P | 0.5?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met-NH2 | 70-1-31B | [Pro9] Substance P | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met[O2]-NH2 | 70-1-22 | [Sar9, Met(O2)11 | 5.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH2 | 70-1-33 | [Sar9] Substance P | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2 | 70-1-18 | [Tyr8] Substance P | 1.0?mg |
| | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Nle-NH2 | 70-1-24 | [Tyr8,Nle11] Substance P | 0.5?mg |
| | Arg-Pro-Pro | 12-1-90 | Bradykinin (1-3) | 5.0?mg |
| | Arg-Pro-Pro-Gly-(pCl)Phe-Ser-Pro-(pCl)Phe-Arg | 18-1-64A | [(pCl)Phe5,8] Bradykinin | 1.0?mg |
| | Arg-Pro-Pro-Gly-(pCl)Phe-Ser-Pro-(pCl)Phe-Arg | 18-1-64B | [(pCl)Phe5,8] Bradykinin | 5.0?mg |
| | Arg-Pro-Pro-Gly-Phe | 18-1-55A | Bradykinin (1-5) | 5.0?mg |
| | Arg-Pro-Pro-Gly-Phe | 18-1-55B | Bradykinin (1-5) | 25.0?mg |
| | Arg-Pro-Pro-Gly-Phe-Ser | 18-1-56A | Bradykinin (1-6) | 5.0?mg |
| | Arg-Pro-Pro-Gly-Phe-Ser | 18-1-56B | Bradykinin (1-6) | 25.0?mg |
| | Arg-Pro-Pro-Gly-Phe-Ser-DPhe-Phe-Arg | 18-1-66 | [DPhe7] Bradykinin | 1.0?mg |
| | Arg-Pro-Pro-Gly-Phe-Ser-Pro | 18-1-57A | Bradykinin (1-7) | 5.0?mg |
| | Arg-Pro-Pro-Gly-Phe-Ser-Pro | 18-1-57B | Bradykinin (1-7) | 25.0?mg |
| | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | 18-1-10 | Bradykinin | 10.0?mg |
| | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg | 18-1-28 | [Tyr8] Bradykinin | 5.0?mg |
| | Arg-Pro-Pro-Gly-Thi-Ser-DPhe-Thi-Arg | 18-1-68A | [Thi5,8,DPhe7] Bradykinin | 1.0?mg |
| | Arg-Pro-Pro-Gly-Thi-Ser-DPhe-Thi-Arg | 18-1-68B | [Thi5,8,DPhe7] Bradykinin | 5.0?mg |
| | Arg-Pro-Pro-Gly-Tyr-Ser-Pro-Phe-Arg | 18-1-30 | [Tyr5] Bradykinin | 5.0?mg |
| | Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | 10-1-32A | ACTH (18-39), human | 0.5?mg |
| | Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | 10-1-32B | ACTH (18-39), human | 1.0?mg |
| | Arg-Ser-Arg | 87-0-76A | R-S-R | 1.0?mg |
| | Arg-Ser-Arg | 87-0-76B | R-S-R | 5.0?mg |
| | Arg-Ser-Arg-Thr-Arg-Gln-Phe-Tyr-Gly-Leu-Met-NH2 | 69-0-01A | Hemokinin 1 (mouse, rat) | 1.0?mg |
| | Arg-Ser-Arg-Thr-Arg-Gln-Phe-Tyr-Gly-Leu-Met-NH2 | 69-0-01B | Hemokinin 1 (mouse, rat) | 5.0?mg |
| | Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-Gly | 46-2-77A | Hypocretin-2-Gly (Human) | 0.5?mg |
| | Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-Gly | 46-2-77B | Hypocretin-2-Gly (Human) | 1.0?mg |
| | Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-Lys-Lys | 46-2-74A | Orexin B[Lys29,30], canine | 0.5?mg |
| | Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-Lys-Lys | 46-2-74B | Orexin B[Lys29,30], canine | 1.0?mg |
| | Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | 46-2-71A | Orexin B, human | 0.5?mg |
| | Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | 46-2-71B | Orexin B, human | 1.0?mg |
| | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys-NH2 | 14-1-45A | Des[Gln18,Ser19,Gly20,22,Leu21] ANP (4-23), amide, rat | 0.5?mg |
| | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys-NH2 | 14-1-45B | Des[Gln18,Ser19,Gly20,22,Leu21] ANP (4-23), amide, rat | 1.0?mg |
| | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg | 14-5-45A | Auriculin A | 0.5?mg |
| | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg | 14-5-45B | Auriculin A | 1.0?mg |
| | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr | 14-5-47A | Auriculin B | 0.5?mg |
| | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr | 14-5-47B | Auriculin B | 1.0?mg |
| | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr | 14-1-38A | Atrial Natriuretic Polypeptide (4-28), human | 0.5?mg |
| | Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr | 14-1-38B | Atrial Natriuretic Polypeptide (4-28), human | 1.0?mg |
| | Arg-Thr-Lys-Arg-Ser-Gly-Ser-Val-Tyr-Glu-Pro-Leu-Lys-Ile | 86-0-42A | Malantide | 0.5?mg |
| | Arg-Thr-Lys-Arg-Ser-Gly-Ser-Val-Tyr-Glu-Pro-Leu-Lys-Ile | 86-0-42B | Malantide | 1.0?mg |
| | Arg-Tyr-Gly-Gly-Phe-Met | 30-0-26A | [Arg0] Met-Enkephalin | 1.0?mg |
| | Arg-Tyr-Gly-Gly-Phe-Met | 30-0-26B | [Arg0] Met-Enkephalin | 5.0?mg |
| | Arg-Tyr-Leu-Gly-Tyr-Leu | 32-3-25 | a-Casein (90-95) | 1.0?mg |
| | Arg-Tyr-Leu-Pro-Thr | 60-0-52 | Proctolin | 1.0?mg |
| | Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys | 72-3-69A | gp38 | 1.0?mg |
| | Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys | 72-3-69B | gp38 | 5.0?mg |
| | Arg-Val-Tyr-Ile-His-Pro-Ile | 12-1-65A | [Ile7] Angiotensin III | 5.0?mg |
| | Arg-Val-Tyr-Ile-His-Pro-Phe | 12-1-61A | Angiotensin III, human | 5.0?mg |
| | Arg-Val-Tyr-Val-His-Pro-Phe | 12-1-64A | [Val4] Angiotensin III | 5.0?mg |
| | Asn-Arg-Asn-Phe-Leu-Arg-Phe-NH2 | 60-9-30 | FMRF Amide Related Peptide. | 1.0?mg |
| | Asn-Arg-Val-Tyr-Ile-His-Pro-Phe | 12-7-23A | Angiotensin II, flounder | 1.0?mg |
| | Asn-Arg-Val-Tyr-Ile-His-Pro-Phe | 12-7-23B | Angiotensin II, flounder | 5.0?mg |
| | Asn-Arg-Val-Tyr-Val-His-Pro-Phe | 12-1-54A | [Asn1,Val5] Angiotensin II | 5.0?mg |
| | Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu | 12-7-25A | [Asn1, Val5, Asn9] Angiotensin I, salmon | 5.0?mg |
| | Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu | 43-0-14A | Uroguanylin, human | 0.5?mg |
| | Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu | 43-0-14B | Uroguanylin, human | 1.0?mg |
| | Asn-Asp-Asp-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Asn-Met-Ile-Glu-Met-Ala-Arg-Ile-Glu-Asn-Glu-Arg-Glu-Gln-Ala-Gly-Leu-Asn-Arg-Lys-Tyr-Leu-Asp-Glu-Val-NH2 | 80-7-15A | Urotensin I | 0.5?mg |
| | Asn-Asp-Asp-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Asn-Met-Ile-Glu-Met-Ala-Arg-Ile-Glu-Asn-Glu-Arg-Glu-Gln-Ala-Gly-Leu-Asn-Arg-Lys-Tyr-Leu-Asp-Glu-Val-NH2 | 80-7-15B | Urotensin I | 1.0?mg |
| | Asn-Gln-Gly-Arg-His-Phe-Cys-Gly-Gly-Ala-Leu-Ile-His-Ala-Arg-Phe-Val-Met-Thr-Ala-Ala-Ser-Cys-Phe-Gln | 72-2-22A | CAP 37 (20-44) | 0.5?mg |
| | Asn-Gln-Gly-Arg-His-Phe-Cys-Gly-Gly-Ala-Leu-Ile-His-Ala-Arg-Phe-Val-Met-Thr-Ala-Ala-Ser-Cys-Phe-Gln | 72-2-22B | CAP 37 (20-44) | 1.0?mg |
| | Asn-Glu-Ala-Tyr-Val-His-Asp-Ala-Pro-Val-Arg-Ser-Leu-Asn | 81-6-80A | N-E-A-Y-V-H-D-A-P-V-R-S-L-N | 0.5?mg |
| | Asn-Glu-Ala-Tyr-Val-His-Asp-Ala-Pro-Val-Arg-Ser-Leu-Asn | 81-6-80B | N-E-A-Y-V-H-D-A-P-V-R-S-L-N | 1.0?mg |
| | Asn-His-Leu-Gln-Gly-Lys-Leu-Ser-Glu-Leu-Gln-Val-Glu-Gln-Thr-Ser-Leu-Glu-Pro-Leu-Gln-Glu-Ser-Pro-Arg | 14-1-93A | BNP (22-46), Pro (Human) | 0.5?mg |
| | Asn-His-Leu-Gln-Gly-Lys-Leu-Ser-Glu-Leu-Gln-Val-Glu-Gln-Thr-Ser-Leu-Glu-Pro-Leu-Gln-Glu-Ser-Pro-Arg | 14-1-93B | BNP (22-46), Pro (Human) | 1.0?mg |
| | Asn-Pro-Asn-Ala-Asn-Pro-Asn-Ala | 79-2-22A | N-P-N-A-N-P-N-A | 0.5?mg |
| | Asn-Pro-Asn-Ala-Asn-Pro-Asn-Ala | 79-2-22B | N-P-N-A-N-P-N-A | 1.0?mg |
| | Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys | 14-1-25A | Cardiodilatin (1-16), human | 1.0?mg |
| | Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys | 14-1-25B | Cardiodilatin (1-16), human | 5.0?mg |
| | Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp | 14-1-32A | Prepro-ANF (26-55), human | 0.5?mg |
| | Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp | 14-1-32B | Prepro-ANF (26-55), human | 1.0?mg |
| | Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-Arg-Leu-Phe | 14-5-11A | BNP (1-32), rat | 0.5?mg |
| | Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-Arg-Leu-Phe | 14-5-11B | BNP (1-32), rat | 1.0?mg |
| | Asn-Thr-Glu-His-Leu-Val-Asp-Ser-Phe-Gln-Glu-Met-Gly | 54-5-41 | GnRH Associated Peptide (GAP) (1-13), rat | 1.0?mg |
| | Asn-Tyr-Pro-Leu-Glu-Leu-Tyr-Glu-Arg-Val-Arg-Thr-Gly-Cys | 86-0-25A | Protein Kinase C (gamma) Peptide | 0.5?mg |
| | Asn-Tyr-Pro-Leu-Glu-Leu-Tyr-Glu-Arg-Val-Arg-Thr-Gly-Cys | 86-0-25B | Protein Kinase C (gamma) Peptide | 1.0?mg |
| | Asn-Val-Ile-Gln-Ile-Ser-Asn-Asp-Leu-Glu-Asn-Leu-Arg | 46-2-10A | Leptin (93-105), human | 0.5?mg |
| | Asn-Val-Ile-Gln-Ile-Ser-Asn-Asp-Leu-Glu-Asn-Leu-Arg | 46-2-10B | Leptin (93-105), human | 1.0?mg |
| | Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | 60-4-16A | Neuropeptide K, porcine | 0.5?mg |
| | Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | 60-4-16B | Neuropeptide K, porcine | 1.0?mg |
| | Asp-Ala-Glu-Ala-Val-Gly-Pro-Glu-Ala-Phe-Ala-Asp-Gln-Asp-Leu-Asp-Glu-Arg-Glu-Val-Arg | 87-9-50A | Magainin Spacer Peptide | 0.5?mg |
| | Asp-Ala-Glu-Ala-Val-Gly-Pro-Glu-Ala-Phe-Ala-Asp-Gln-Asp-Leu-Asp-Glu-Arg-Glu-Val-Arg | 87-9-50B | Magainin Spacer Peptide | 1.0?mg |
| | Asp-Ala-Glu-Asn-Leu-Ile-Asp-Ser-Phe-Gln-Glu-Ile-Val | 54-1-40 | GnRH Associated Peptide (GAP) (1-13), human | 1.0?mg |
| | Asp-Ala-Glu-Asn-Leu-Ile-Asp-Ser-Phe-Gln-Glu-Ile-Val-Lys-Glu-Val-Gly-Gln-Leu-Ala-Glu-Thr-Gln-Arg | 54-1-39A | GnRH Associated Peptide (GAP) (1-24), human | 0.5?mg |
| | Asp-Ala-Glu-Asn-Leu-Ile-Asp-Ser-Phe-Gln-Glu-Ile-Val-Lys-Glu-Val-Gly-Gln-Leu-Ala-Glu-Thr-Gln-Arg | 54-1-39B | GnRH Associated Peptide (GAP) (1-24), human | 1.0?mg |
| | Asp-Ala-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | 60-7-20A | g-Neuropeptide, rabbit | 0.5?mg |
| | Asp-Ala-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | 60-7-20B | g-Neuropeptide, rabbit | 1.0?mg |
| | Asp-Ala-Phe-Val-b-Ala-Leu-Met-NH2 | 62-1-45A | [Ala5,b-Ala8] Neurokinin A (4-10) | 0.5?mg |
| | Asp-Ala-Phe-Val-b-Ala-Leu-Met-NH2 | 62-1-45B | [Ala5,b-Ala8] Neurokinin A (4-10) | 1.0?mg |
| | Asp-Ala-Ser-Phe-His-Ser-Trp-Gly-NH2 | 33-1-21 | Leucokinin IV | 1.0?mg |
| | Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 | 87-7-40A | Allatostatin IV | 1.0?mg |
| | Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 | 87-7-40B | Allatostatin IV | 5.0?mg |
| | Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys | 34-7-35A | Cortistatin-17, human | 0.5?mg |
| | Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys | 34-7-35B | Cortistatin-17, human | 1.0?mg |
| | Asp-Arg-Val-Tyr | 12-1-37A | Angiotensin II (1-4), human | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-D-Ala | 12-7-26A | A-779 | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro | 12-1-11A | Angiotensin, Canine, Rat | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Cys-His-Leu-Leu-Tyr-Tyr-Ser | 12-2-20A | [Cys8] Renin Substrate Tetradecapeptide, rat | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Cys-His-Leu-Leu-Tyr-Tyr-Ser | 12-2-20B | [Cys8] Renin Substrate Tetradecapeptide, rat | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Leu-His-Leu-Leu-Tyr-Tyr-Ser | 12-2-30A | [Leu8] Renin Substrate Tetradecapeptide, rat | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Leu-His-Leu-Leu-Tyr-Tyr-Ser | 12-2-30B | [Leu8] Renin Substrate Tetradecapeptide, rat | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | 12-1-34A | Angiotensin II, human | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu | 12-1-10A | Angiotensin I, human | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-Tyr-Ser | 12-2-10A | Renin Substrate Tetradecapeptide, rat | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-Tyr-Ser | 12-2-10B | Renin Substrate Tetradecapeptide, rat | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser | 12-1-67A | Angiotensinogen (1-14), porcine | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser | 12-1-67B | Angiotensinogen (1-14), porcine | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His | 12-1-71A | Angiotensinogen (1-13), human | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His | 12-1-71B | Angiotensinogen (1-13), human | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn | 12-1-77A | Angiotensinogen (1-14), human | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn | 12-1-77B | Angiotensinogen (1-14), human | 5.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Val-His-Leu-Leu-Tyr-Tyr-Ser | 12-2-40A | [Val8] Renin Substrate Tetradecapeptide, rat | 1.0?mg |
| | Asp-Arg-Val-Tyr-Ile-His-Pro-Val-His-Leu-Leu-Tyr-Tyr-Ser | 12-2-40B | [Val8] Renin Substrate Tetradecapeptide, rat | 5.0?mg |
| | Asp-Arg-Val-Tyr-Val-His-Pro-Phe | 12-1-41 | [Val5] Angiotensin II, human | 5.0?mg |
| | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 12-1-27A | [Val5] Angiotensin I, human | 5.0?mg |
| | Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 | 34-7-16A | Urocortin, human | 0.5?mg |
| | Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 | 34-7-16B | Urocortin, human | 1.0?mg |
| | Asp-Asp-Asp-Asp-Asp | 87-0-71 | D-D-D-D-D | 1.0?mg |
| | Asp-Asp-Asp-Asp-Asp-Asp | 87-0-74 | D-D-D-D-D-D | 1.0?mg |
| | Asp-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2 | 70-1-97A | [Asp5,6,Me-Phe8] Substance P | 1.0?mg |
| | Asp-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2 | 70-1-97B | [Asp5,6,Me-Phe8] Substance P | 5.0?mg |
| | Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 | 34-7-17A | Urocortin, rat | 0.5?mg |
| | Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 | 34-7-17B | Urocortin, rat | 1.0?mg |
| | Asp-DPro-His-Asp-Phe-DTrp-Val-DTrp-Leu-Nle-NH2 | 62-0-45A | [DPro2,DTrp6,8,Nle10] Neurokinin B | 0.5?mg |
| | Asp-DPro-His-Asp-Phe-DTrp-Val-DTrp-Leu-Nle-NH2 | 62-0-45B | [DPro2,DTrp6,8,Nle10] Neurokinin B | 1.0?mg |
| | Asp-Gln-Gly-Phe-Asn-Ser-Trp-Gly-NH2 | 33-1-19 | Leucokinin III | 1.0?mg |
| | Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | 56-4-31 | b-MSH, porcine | 1.0?mg |
| | Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg | 22-1-65A | Osteocalcin 30-43 Fragment | 1.0?mg |
| | Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg | 22-1-65B | Osteocalcin 30-43 Fragment | 5.0?mg |
| | Asp-Glu-Leu-Pro-Gln-Leu-Val-Thr-Leu-Pro-His-Pro-Asn-Leu-His-Gly-Pro-Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr | 44-0-50A | Fibronectin Type III Connecting Segment ?(1-25) | 0.5?mg |
| | Asp-Glu-Leu-Pro-Gln-Leu-Val-Thr-Leu-Pro-His-Pro-Asn-Leu-His-Gly-Pro-Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr | 44-0-50B | Fibronectin Type III Connecting Segment ?(1-25) | 1.0?mg |
| | Asp-Glu-Pro-Asn-Ser-Asp-Gln-Phe-Ile-Gly-Leu-Met-NH2 | 46-0-10 | Entero-Kassinin | 1.0?mg |
| | Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys | 72-2-12 | b-Defensin-1, human | 0.1?mg |
| | Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys | 14-1-42A | C-Type Natriuretic Peptide (1-53), human | 0.5?mg |
| | Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys | 14-1-42B | C-Type Natriuretic Peptide (1-53), human | 1.0?mg |
| | Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu | 81-6-10 | Calcineurin Substrate | 1.0?mg |
| | Asp-Leu-Pro-Lys-Ile-Asn-Arg-Lys-Gly-Pro-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-NH2 | 18-1-15A | Bombinakinin M | 0.5?mg |
| | Asp-Leu-Pro-Lys-Ile-Asn-Arg-Lys-Gly-Pro-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-NH2 | 18-1-15B | Bombinakinin M | 1.0?mg |
| | Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | 46-3-10A | Exendin (9-39) | 0.5?mg |
| | Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | 46-3-10B | Exendin (9-39) | 1.0?mg |
| | Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2 | 34-0-15A | a-Helical Corticotropin Releasing Factor (9-41) | 0.5?mg |
| | Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2 | 34-0-15B | a-Helical Corticotropin Releasing Factor (9-41) | 1.0?mg |
| | Asp-Leu-Trp-Gln-Lys | 87-0-12A | Uremic Pentapeptide | 1.0?mg |
| | Asp-Leu-Trp-Gln-Lys | 87-0-12B | Uremic Pentapeptide | 5.0?mg |
| | Asp-Lys-Phe-Val-Gly-Leu(N-Me)-NIe-NH2 | 62-1-49A | [Lys5, MeLeu9, NIe10]-Neurokinin A (4-10) | 1.0?mg |
| | Asp-Lys-Phe-Val-Gly-Leu(N-Me)-NIe-NH2 | 62-1-49B | [Lys5, MeLeu9, NIe10]-Neurokinin A (4-10) | 5.0?mg |
| | Asp-Met-Ala-Lys-Asp-Leu-Glu-Thr-Asn-His-His-Pro-Tyr-Phe-Gly-Asn | 22-5-20A | Calcitonin C-terminal Adjacent Peptide, rat | 0.5?mg |
| | Asp-Met-Ala-Lys-Asp-Leu-Glu-Thr-Asn-His-His-Pro-Tyr-Phe-Gly-Asn | 22-5-20B | Calcitonin C-terminal Adjacent Peptide, rat | 1.0?mg |
| | Asp-Met-His-Asp-Phe-Phe-MePhe-Gly-Leu-Met-NH2 | 62-1-47A | (N-Me-Phe7)-Neurokinin B | 1.0?mg |
| | Asp-Met-His-Asp-Phe-Phe-MePhe-Gly-Leu-Met-NH2 | 62-1-47B | (N-Me-Phe7)-Neurokinin B | 5.0?mg |
| | Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 | 62-1-42A | Neurokinin B | 0.5?mg |
| | Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 | 62-1-42B | Neurokinin B | 1.0?mg |
| | Asp-Met-Ser-Ser-Asp-Leu-Glu-Arg-Asp-His-Arg-Pro-His-Val-Ser-Met-Pro-Gln-Asn-Ala-Asn | 22-0-15A | Katacalcin | 0.5?mg |
| | Asp-Met-Ser-Ser-Asp-Leu-Glu-Arg-Asp-His-Arg-Pro-His-Val-Ser-Met-Pro-Gln-Asn-Ala-Asn | 22-0-15B | Katacalcin | 1.0?mg |
| | Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val | 72-0-62A | Melanin Concentrating Hormone, rat | 0.5?mg |
| | Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val | 72-0-62B | Melanin Concentrating Hormone, rat | 1.0?mg |
| | Asp-Pro-Ala-Phe-Asn-Ser-Trp-Gly-NH2 | 33-1-14 | Leucokinin I | 1.0?mg |
| | Asp-Pro-Ala-Phe-Ser-Ser-Trp-Gly-NH2 | 33-1-28 | Leucokinin VII | 1.0?mg |
| | Asp-Pro-Gly-Phe-Ser-Ser-Trp-Gly-NH2 | 33-1-17 | Leucokinin II | 1.0?mg |
| | Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala | 81-5-40 | Calpain Inhibitor Peptide | 0.5?mg |
| | Asp-Pro-Pro-Asn-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 | 69-0-04A | Entero-Hylambatin | 0.5?mg |
| | Asp-Pro-Pro-Asn-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 | 69-0-04B | Entero-Hylambatin | 1.0?mg |
| | Asp-Pro-Pro-Asp-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 | 62-1-32A | Hylambatin | 0.5?mg |
| | Asp-Pro-Pro-Asp-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 | 62-1-32B | Hylambatin | 1.0?mg |
| | Asp-Ser-Ala-Pro-Asn-Pro-Val-Leu-Asp-Ile-Asp-Gly-Glu-Lys-Leu-Arg-Thr-Gly-Thr-Asn | 82-8-10 | Miraculin (1-20) | 1.0?mg |
| | Asp-Ser-Asp-Pro-Arg | 82-0-51 | Human IgE Pentapeptide HEPP | 5.0?mg |
| | Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr | 14-4-15A | BNP (7-32), porcine | 0.5?mg |
| | Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr | 14-4-15B | BNP (7-32), porcine | 1.0?mg |
| | Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr | 72-2-25A | Histatin 5 | 0.5?mg |
| | Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr | 72-2-25B | Histatin 5 | 1.0?mg |
| | Asp-Ser-Phe-Val-b-Ala-Leu-Met-NH2 | 62-1-46A | (b-Ala8)-Neurokinin A (4-10) | 0.5?mg |
| | Asp-Ser-Phe-Val-b-Ala-Leu-Met-NH2 | 62-1-46B | (b-Ala8)-Neurokinin A (4-10) | 1.0?mg |
| | Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | 62-1-50 | Neurokinin A (4-10) | 1.0?mg |
| | Asp-Thr-Ala-Ser-Asp-Ala-Ala-Ala-Ala-Ala-Ala-Leu-Thr-Ala-Ala-Asn-Ala-Lys-Ala-Ala-Ala-Glu-Leu-Thr-Ala-Ala-Asn-Ala-Ala-Ala-Ala-Ala-Ala-Ala-Thr-Ala-Arg | 79-2-10A | Antifreeze Polypeptide (AFP) (HPLC-6), Winter Flounder | 0.5?mg |
| | Asp-Thr-Ala-Ser-Asp-Ala-Ala-Ala-Ala-Ala-Ala-Leu-Thr-Ala-Ala-Asn-Ala-Lys-Ala-Ala-Ala-Glu-Leu-Thr-Ala-Ala-Asn-Ala-Ala-Ala-Ala-Ala-Ala-Ala-Thr-Ala-Arg | 79-2-10B | Antifreeze Polypeptide (AFP) (HPLC-6), Winter Flounder | 1.0?mg |
| | Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr | 87-9-65 | Liver-Expressed Antimicrobial Peptide, Human | 0.1?mg |
| | Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val | 72-0-61A | Melanin Concentrating Hormone, salmon | 0.5?mg |
| | Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val | 72-0-61B | Melanin Concentrating Hormone, salmon | 1.0?mg |
| | Asp-Thr-Ser-His-His-Asp-Gln-Asp-His-Pro-Thr-Phe-Asp-NH2 | 54-1-51 | Gonadotropin Releasing Peptide, follicular, human | 1.0?mg |
| | Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 | 46-1-32A | Cholecystokinin, CCK Octapeptide (26-33) | 0.5?mg |
| | Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 | 46-1-32B | Cholecystokinin, CCK Octapeptide (26-33) | 1.0?mg |
| | Asp-Tyr-DTrp-Val-DTrp-DTrp-Arg-NH2 | 62-1-30A | [Tyr5, DTrp6,8,9,Arg10] Neurokinin A (4-10) | 0.5?mg |
| | Asp-Tyr-DTrp-Val-DTrp-DTrp-Arg-NH2 | 62-1-30B | [Tyr5, DTrp6,8,9,Arg10] Neurokinin A (4-10) | 1.0?mg |
| | Asp-Tyr-DTrp-Val-DTrp-DTrp-Lys-NH2 | 62-1-39A | Men 10376 | 0.5?mg |
| | Asp-Tyr-DTrp-Val-DTrp-DTrp-Lys-NH2 | 62-1-39B | Men 10376 | 1.0?mg |
| | Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys | 82-8-20A | Flag Peptide | 0.5?mg |
| | Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys | 82-8-20B | Flag Peptide | 1.0?mg |
| | Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe | 46-1-36A | Cholecystokinin (26-33), free acid; CCK Octapeptide, non-sulfated | 0.5?mg |
| | Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe | 46-1-36B | Cholecystokinin (26-33), free acid; CCK Octapeptide, non-sulfated | 1.0?mg |
| | Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | 46-1-33A | Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | 0.5?mg |
| | Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | 46-1-33B | Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | 1.0?mg |
| | Asp-Val-Ala-His-Glu-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Arg-Lys-Tyr-Leu-Gln-Ser-Met-Val-Ala | 34-0-52A | PACAP-Related Peptide (PRP), rat | 0.5?mg |
| | Asp-Val-Ala-His-Glu-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Arg-Lys-Tyr-Leu-Gln-Ser-Met-Val-Ala | 34-0-52B | PACAP-Related Peptide (PRP), rat | 1.0?mg |
| | Asp-Val-Ala-His-Gly-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Gly-Lys-His-Leu-Gln-Ser-Leu-Val-Ala | 34-0-22A | PACAP-Related Peptide (PRP), human | 0.5?mg |
| | Asp-Val-Ala-His-Gly-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Gly-Lys-His-Leu-Gln-Ser-Leu-Val-Ala | 34-0-22B | PACAP-Related Peptide (PRP), human | 1.0?mg |
| | Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH2 | 62-0-55 | Kassinin | 1.0?mg |
| | Asp-Val-Ser-Asp-Gly-Ser-Ala-Glu-Arg-Arg-Pro-Tyr-Thr-Arg-Met-Gly-Ser-Gly-Gly-Leu-Lys-Leu-His-Cys-Val-His-Pro-Ala-Asn-Cys-Pro-Gly-Gly-Leu-Met-Val-Thr | 60-0-75A | Neuron Specific Peptide | 0.5?mg |
| | Asp-Val-Ser-Asp-Gly-Ser-Ala-Glu-Arg-Arg-Pro-Tyr-Thr-Arg-Met-Gly-Ser-Gly-Gly-Leu-Lys-Leu-His-Cys-Val-His-Pro-Ala-Asn-Cys-Pro-Gly-Gly-Leu-Met-Val-Thr | 60-0-75B | Neuron Specific Peptide | 1.0?mg |
| | Asp-Val-Ser-Thr-Pro-Pro-Thr-Val-Leu-Pro-Asp-Asn-Phe-Pro-Arg-Tyr | 50-1-37 | Insulin-Like Growth Factor II (69-84) | 1.0?mg |
| | Asp-Val-Val-Asp-Ala-Asp-Glu-Tyr-Leu-Ile-Pro-Gln | 50-0-24 | Epidermal Growth Factor Receptor Peptide (985-996) | 1.0?mg |
